Revian Red Hair Growth System in Second Study for Treatment of Central Centrifugal Cicatricial Alopecia After Promising First Study Results
REVIAN Inc., an aesthetic medical technology company using precise wavelengths of LED light to rejuvenate hair and skin, announced today that its Revian Red Hair Growth System will be in a second study to build on previous trial results as an effective treatment for Central Centrifugal Cicatricial Alopecia (“CCCA”). CCCA is a form of scarring hair loss that predominately affects middle-aged women of African descent. CCCA has no known cure and can cause permanent hair loss which often results in psychological distress affecting overall quality of life.